retatrutide clinical trial sign up FDA Approval Status: July 2026 Update Reta clinical trial data &

So, youll need to find a lab in your local area that works with your current health coverage

The mean duration of diabetes was 16 years

While traditionally recognized for its role in glucose homeostasis and insulin secretion, GLP-1 exerts significant effects on the central nervous system through activation of GLP-1 receptors (GLP-1R) distributed throughout various brain regions

The company says it can help patients lose the weight and keep it off Virta released a study in February 2024 showing its program can help diabetes patients maintain their weight loss after they stop taking GLP-1s

While some studies suggest protective effects, others raise concerns about potential oncogenic associations

In a phase 3 trial (REDEFINE-2) of adults with T2DM and a BMI of 27 kg/m 2 and above, combining the GLP-1 receptor agonist semaglutide with the long-acting amylin analogue cagrilintide resulted in greater weight loss than placebo at 68 weeks (13.7% vs 3.4%)